Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 522.00
-5.95 (-1.13%)
Mar 9, 2026, 12:22 PM IST
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 11.75 billion as of March 6, 2026. Its market cap has increased by 131.40% in one year.
Market Cap
11.75B
Enterprise Value
12.60B
Revenue
2.31B
Ranking
n/a
PE Ratio
46.45
Stock Price
522.00
Market Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 11.75B, an increase of 1,997.25%. That is a compound annual growth rate of 43.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.75B | 29.02% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 40.23B |
| Innova Captab | 38.91B |
| RPG Life Sciences | 30.97B |
| Orchid Pharma | 25.79B |
| Solara Active Pharma Sciences | 22.11B |
| Indoco Remedies | 18.31B |
| Windlas Biotech | 15.58B |
| Ind-Swift Laboratories | 11.87B |